. 2019 Feb 28;34(2):e201900208. doi: 10.1590/s0102-8650201900208

Table 2. Effect of icariside II on SOD, GSH-Px, catalase and MDA levels in brain tissue.

Group	SOD (U/mg)	GSH-Px (U/mg)	Catalase (U/mg)	MDA (nmol/mg)
Sham-operated	16.29±2.44	18.55±3.45	5.12±1.12	4.58±1.05
Model	8.95±2.02^*	10.67±2.73^*	2.27±0.34^*	8.48±1.77^*
5 mg/kg icariside II	9.34±2.15^*	11.38±2.42^*	2.58±0.47^*	7.05±1.43^*#
10 mg/kg icariside II	10.03±2.34^*	12.31±2.83^*#	3.17±0.59^*#	6.33±1.31^*#$
20 mg/kg icariside II	12.27±2.63^*#$	14.39±2.94^*#$	4.21±0.49^*#$※	5.74±1.09^*#$※

Values are mean±SD. ^*P < 0.05 vs sham-operated group; ^#P < 0.05 vs model group; ^$P < 0.05 vs 5 mg/kg icariside II group; ^※P < 0.05 vs 10 mg/kg icariside II group. SOD, superoxide dismutase; GSH-Px, glutathione peroxidase; MDA, malondialdehyde.